Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that FDA has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.
Eton Pharmaceuticals announced Biorphen?, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension ...
In adults with recent stroke, a lower systolic blood pressure (SBP) goal may reduce the risk for orthostatic hypotension (OH) without any effect on orthostatic symptoms...